{"id":43171,"date":"2016-09-09T09:47:10","date_gmt":"2016-09-09T14:17:10","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=43171"},"modified":"2016-09-09T18:01:22","modified_gmt":"2016-09-09T22:31:22","slug":"genital-herpes","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/43171","title":{"rendered":"Genital Herpes"},"content":{"rendered":"<p><!--more--><\/p>\n<p>John W. Gnann, Jr., M.D., and Richard J. Whitley, M.D <strong>Genital Herpes. The new england journal o f medicine<\/strong> 375;7 nejm.org August 18, 2016<\/p>\n<p><strong>Una guia esencial del manejo del Herpes genital, algunos tips terapeuticos<\/strong><\/p>\n<p>-Acyclovir 400 mg 3 times a day for 7\u201310 days or 200 mg 5 times a day for 7\u201310 days<br \/>\n-Valacyclovir 1 g twice a day for 7\u201310 days<br \/>\n-Famciclovir 250 mg 3 times a day for 7\u201310 days<\/p>\n<p><strong>Episodic therapy for recurrent genital herpes<\/strong><\/p>\n<p>-Acyclovir 400 mg 3 times a day for 5 days or 800 mg twice a day for 5 days or 800 mg 3 times a day for 2 days<br \/>\n-Valacyclovir 500 mg twice a day for 3 days or 1 g once a day for 5 days<br \/>\n-Famciclovir 125 mg twice a day for 5 days or 1 g every 12 hr for 2 doses or 500 mg for 1 dose followed by 250 mg twice a day for 2 days<\/p>\n<p><strong>Suppressive therapy For recurrent genital herpes<\/strong><\/p>\n<p>Acyclovir 400 mg twice a day Valacyclovir 500 mg once a day or 1 g once a day<br \/>\nFamciclovir 250 mg twice a day In pregnancy (beginning at 36 wk of gestation)\u2021<br \/>\nAcyclovir 400 mg 3 times a day Valacyclovir 500 mg twice a day *<\/p>\n<p><strong>In pregnancy (beginning at 36 wk of gestation)<\/strong><\/p>\n<p>\u2021 Acyclovir 400 mg 3 times a day<br \/>\nValacyclovir 500 mg twice a day<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-43171","post","type-post","status-publish","format-standard","","category-articulos-cientificos"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/43171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=43171"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/43171\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=43171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=43171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=43171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}